Capricor Therapeutics, Inc. (CAPR)
27.04
-0.98
(-3.48%)
USD |
NASDAQ |
May 19, 12:03
Capricor Therapeutics Research and Development Expense (Quarterly) : 27.10M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Curis, Inc. | 6.449M |
| Inovio Pharmaceuticals, Inc. | 13.75M |
| Vaxart, Inc. | 29.41M |
| Kura Oncology, Inc. | 65.26M |
| Allogene Therapeutics, Inc. | 29.13M |